69097-430 : Nypozi 300 ug/300ug Intravenous; Subcutaneous Injection
| NDC: | 69097-430 |
| Labeler: | Cipla USA Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Nypozi |
| Dosage Form: | Intravenous; Subcutaneous Injection |
| Application #: | BLA761126 |
| Rev. Date: |
NDC Package Codes:
- 69097-430-67: 1 SYRINGE, GLASS IN 1 CARTON (69097‑430‑67) / 300 UG IN 1 SYRINGE, GLASS
- 69097-430-96: 10 SYRINGE, GLASS IN 1 CARTON (69097‑430‑96) / 300 UG IN 1 SYRINGE, GLASS
Active Ingredients:
- Filgrastim
Dosage Strength:
- 300 ug/300ug
Pharmaceutical Classes:
- Granulocyte Colony-Stimulating Factor [CS]
- Increased Myeloid Cell Production [PE]
- Leukocyte Growth Factor [EPC]
Related Products:
Based on records with the same trade name.- 69097-429 Nypozi 480 ug/480ug Intravenous; Subcutaneous Injection by Cipla USA Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69097-429Next: 69097-431 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.